Alicia Harbison
Family Medicine · Pantego, TXNPI 1306209119
Payments from drug & device makers
Across 403 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$972
- Welch Allyn$851
- Lilly USA, LLC$760
- Baxter Healthcare$625
- Novo Nordisk$577
- Pfizer$367
- plus $3K from 39 others
What the payments were for
- Food & beverage$5,63077%
- Education$1993%
- Other$1,47620%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$851
- Hillrom - CardioPerfect PRO ECG Recorder$525
How this compares
$7,304 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 31 | $33,197 |
| OzempicSemaglutide | 24 | $33,069 |
| MounjaroTirzepatide | 20 | $29,583 |
| EliquisApixaban | 21 | $23,481 |
| JardianceEmpagliflozin | 13 | $22,645 |
| LinzessLinaclotide | 11 | $6,875 |
| Quetiapine Fumarate | 15 | $1,714 |
| Duloxetine Hcl | 41 | $1,491 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $1,415 |
| Atorvastatin Calcium | 146 | $1,273 |
| Gabapentin | 68 | $1,257 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $1,002 |
| Levothyroxine Sodium | 134 | $806 |
| Pantoprazole Sodium | 81 | $761 |
| Celecoxib | 57 | $751 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $760 | $62,78051 claims |
| Novo NordiskOzempic | $577 | $33,06924 claims |
| PfizerEliquis | $367 | $23,48121 claims |
| Boehringer IngelheimJardiance | $109 | $22,64513 claims |
| AbbVieLinzess | $972 | $6,87511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Pantego
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.